In a major boost to medical education in India, the Union Cabinet has approved Phase-III of the Centrally Sponsored Scheme to add over 10,000 new medical seats, including 5023 MBBS and 5000 PG medical seats, in government-run medical institutes, by 2028-29. With a total outlay of Rs 15,034.50 crore, the initiative will expand opportunities for aspiring doctors, ensure more specialists, and strengthen healthcare access in underserved regions. According to the statement issued by the Centre, the Union Cabinet chaired by the Prime Minister, Shri Narendra Modi, has approved the Phase-Ill of the Centrally Sponsored Scheme (CSS) for strengthening and upgradation of existing State Government/ Central Government Medical Colleges/ Standalone PG Institutes/ Government Hospitals for increasing 5,000PG seatsand extension of the CSS for upgradation of existing government medical colleges for increasing 5,023MBBSseats with an enhanced cost ceiling of Rs 1.50 crore per seat. For more details, check out the full story on the link mentioned below: Over 10,000 MBBS and PG Medical Seats To be Added by 2028-29 in India
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!